retatrutide trial weight loss data Triple hormone receptor agonist for metabolic dysfunction-associated steatotic liver disease: a randomized phase 2a Retatrutide's July 23 Phase 3

What about regulatory scrutiny

Dealing With the Unexpected Side Effects of GLP-1s Nausea and stomach problems are well-known side effects of GLP-1s, but you may be less familiar with other pros and cons of these powerful medications

Matt, if someone were to have a thyroid nodule, what kind of symptoms would you be asking the patient about

The conventional story of Alzheimers disease (AD) has long revolved around the accumulation of amyloid plaques and tau tangles

While both medications activate GLP-1 receptors to reduce appetite and enhance satiety, semaglutide is simply a more potent and longer-acting molecule

& Goodrich-Blair, H